- Home
- UGP vs PTGX Comparison
UGP vs PTGX Comparison
Compare UGP & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UGP | PTGX |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.4B |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | UGP | PTGX |
|---|---|---|
| Price | $3.93 | $94.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $4.50 | ★ $88.33 |
| AVG Volume (30 Days) | ★ 1.9M | 902.1K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 13.71 | N/A |
| EPS | 0.50 | ★ 0.72 |
| Revenue | ★ $26,235,514,649.00 | $209,217,000.00 |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $1.46 | $296.47 |
| P/E Ratio | ★ $7.47 | $132.27 |
| Revenue Growth | ★ 6.31 | N/A |
| 52 Week Low | $2.53 | $33.70 |
| 52 Week High | $4.40 | $95.26 |
Technical Indicators
Market Signals| Indicator | UGP | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 70.99 |
| Support Level | $3.83 | $88.30 |
| Resistance Level | $4.08 | $92.80 |
| Average True Range (ATR) | 0.11 | 2.82 |
| MACD | -0.03 | 0.19 |
| Stochastic Oscillator | 16.67 | 94.19 |
Price Performance
Historical ComparisonAbout UGP Ultrapar Participacoes S.A.
Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The Company has three business segments: Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. The Ipiranga engages in the distribution and sale of oil-related products, biofuels, and similar products to service stations that operate under the Ipiranga brand throughout Brazil and to consumers and carrier-reseller-retailer. The Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers of Brazil.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.